151 related articles for article (PubMed ID: 38037320)
1. Clinical Outcomes of Small Cell Carcinoma of the Genitourinary Tract and the Prognostic Significance of the Tumor Immune Microenvironment.
Hyung J; Kim HD; Kim GH; Cho YM; Ryu YM; Kim SY; Park I; Yoon S; Lee JL
Cancer Res Treat; 2024 Apr; 56(2):624-633. PubMed ID: 38037320
[TBL] [Abstract][Full Text] [Related]
2. Genitourinary small cell carcinoma: a retrospective review of treatment and survival patterns at The Ottawa Hospital Regional Cancer Center.
Asmis TR; Reaume MN; Dahrouge S; Malone S
BJU Int; 2006 Apr; 97(4):711-5. PubMed ID: 16536759
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of small cell lung cancer patients treated with cisplatin-etoposide versus carboplatin-etoposide.
Karam I; Jiang SY; Khaira M; Lee CW; Schellenberg D
Am J Clin Oncol; 2015 Feb; 38(1):51-4. PubMed ID: 23563211
[TBL] [Abstract][Full Text] [Related]
4. Extrapulmonary small cell carcinoma: the University of Kansas experience and review of literature.
Dakhil CS; Wick JA; Kumar AK; Satyan MT; Neupane P
Med Oncol; 2014 Oct; 31(10):187. PubMed ID: 25151532
[TBL] [Abstract][Full Text] [Related]
5. Genitourinary small-cell carcinoma: a single-institution experience.
Pervez N; El-Gehani F; Joseph K; Dechaphunkul A; Kamal M; Pertschy D; Venner P; Ghosh S; North S
Curr Oncol; 2013 Oct; 20(5):258-64. PubMed ID: 24155630
[TBL] [Abstract][Full Text] [Related]
6. High Systemic Immune-Inflammation Index (SII) Represents an Unfavorable Prognostic Factor for Small Cell Lung Cancer Treated with Etoposide and Platinum-Based Chemotherapy.
Wang C; Jin S; Xu S; Cao S
Lung; 2020 Apr; 198(2):405-414. PubMed ID: 32016563
[TBL] [Abstract][Full Text] [Related]
7. A 20-year retrospective study of small-cell carcinomas in Taiwan.
Li AF; Hsu HS; Hsu CY; Li AC; Li WY; Liang WY; Chen JY
J Surg Oncol; 2010 Oct; 102(5):497-502. PubMed ID: 20872953
[TBL] [Abstract][Full Text] [Related]
8. Extrapulmonary small cell carcinoma: single center experience with 61 patients.
Lee SS; Lee JL; Ryu MH; Chang HM; Kim TW; Kim WK; Lee JS; Jang SJ; Khang SK; Kang YK
Acta Oncol; 2007; 46(6):846-51. PubMed ID: 17653910
[TBL] [Abstract][Full Text] [Related]
9. Current trend of worsening prognosis of prostate small cell carcinoma: A population-based study.
Wang J; Liu X; Wang Y; Ren G
Cancer Med; 2019 Nov; 8(15):6799-6806. PubMed ID: 31518071
[TBL] [Abstract][Full Text] [Related]
10. Genitourinary small-cell carcinoma: 11-year treatment experience.
Chang K; Dai B; Kong YY; Qu YY; Gan HL; Gu WJ; Ye DW; Zhang HL; Zhu Y; Shi GH
Asian J Androl; 2014; 16(5):705-9. PubMed ID: 24713837
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of extensive stage extrapulmonary small cell cancer.
Gandy G; Yip PY; Tognela A; Hayat F; Fox W; Kok PS
Intern Med J; 2023 Sep; 53(9):1556-1563. PubMed ID: 36043900
[TBL] [Abstract][Full Text] [Related]
12. Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors.
Ma VT; Su CT; Hu M; Taylor JMG; Daignault-Newton S; Kellezi O; Dahl MN; Shah MA; Erickson S; Lora J; Hamasha R; Ali A; Yancey S; Kiros L; Balicki HM; Winfield DC; Green MD; Alva AS
Urol Oncol; 2021 Jul; 39(7):437.e1-437.e9. PubMed ID: 33495117
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of pretreatment lung immune prognostic index in extensive-stage small-cell lung cancer treated with platinum plus etoposide chemotherapy.
Qi W; Zhao S; Chen J
Cancer Biomark; 2021; 31(2):177-185. PubMed ID: 33896825
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of concurrent chemoradiotherapy for patients with limited-disease small-cell lung cancer: a retrospective, nationwide, population-based cohort study.
Kim SR; Hong JH; Sung SY; Kim YH; Chun SH; Lee HW; Lee JS; Ko YH
BMC Cancer; 2021 Mar; 21(1):340. PubMed ID: 33789628
[TBL] [Abstract][Full Text] [Related]
15. The landscape of immune microenvironment in lung adenocarcinoma and squamous cell carcinoma based on PD-L1 expression and tumor-infiltrating lymphocytes.
Chen L; Cao MF; Zhang X; Dang WQ; Xiao JF; Liu Q; Tan YH; Tan YY; Xu YY; Xu SL; Yao XH; Cui YH; Zhang X; Bian XW
Cancer Med; 2019 Dec; 8(17):7207-7218. PubMed ID: 31605439
[TBL] [Abstract][Full Text] [Related]
16. [First-line chemotherapy and its survival analysis of 394 patients with extensive-stage small cell lung cancer in a single institute].
Ma M; Wang M; Xu Y; Hu K; Liu H; Li L; Zhong W; Zhang L; Zhao J; Wang H
Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):8-14. PubMed ID: 24398308
[TBL] [Abstract][Full Text] [Related]
17. Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer.
Reck M; Luft A; Szczesna A; Havel L; Kim SW; Akerley W; Pietanza MC; Wu YL; Zielinski C; Thomas M; Felip E; Gold K; Horn L; Aerts J; Nakagawa K; Lorigan P; Pieters A; Kong Sanchez T; Fairchild J; Spigel D
J Clin Oncol; 2016 Nov; 34(31):3740-3748. PubMed ID: 27458307
[TBL] [Abstract][Full Text] [Related]
18. Extrapulmonary small cell carcinoma (EPSCC): 10 years' multi-disciplinary experience at Charité.
Ochsenreither S; Marnitz-Schultze S; Schneider A; Koehler C; Daum S; Loddenkemper C; Budach V; Thiel E; Keilholz U; Schmittel A
Anticancer Res; 2009 Aug; 29(8):3411-5. PubMed ID: 19661365
[TBL] [Abstract][Full Text] [Related]
19. Retrospective review of extra-pulmonary small cell carcinoma and prognostic factors.
Brammer JE; Lulla P; Lynch GR
Int J Clin Oncol; 2014 Oct; 19(5):822-8. PubMed ID: 24122253
[TBL] [Abstract][Full Text] [Related]
20. Contemporary Incidence and Cancer Control Outcomes of Primary Neuroendocrine Prostate Cancer: A SEER Database Analysis.
Zaffuto E; Pompe R; Zanaty M; Bondarenko HD; Leyh-Bannurah SR; Moschini M; Dell'Oglio P; Gandaglia G; Fossati N; Stabile A; Zorn KC; Montorsi F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2017 Oct; 15(5):e793-e800. PubMed ID: 28506524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
